Cargando…

The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1–associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation

Because there are limited clinical reports on the impact of human T-lymphotropic virus type 1 (HTLV-1) on organ transplantation, its effects on the development of adult T-cell leukemia-lymphoma (ATL), post-transplantation lymphoproliferative disorder (PTLD) and HTLV-1–associated myelopathy (HAM) or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawano, Noriaki, Yoshida, Shuro, Kawano, Sayaka, Kuriyama, Takuro, Tahara, Yoshihiro, Toyofuku, Atsushi, Manabe, Tatsuya, Doi, Atsushi, Terasaka, Soushi, Yamashita, Kiyoshi, Ueda, Yuji, Ochiai, Hidenobu, Marutsuka, Kousuke, Yamano, Yoshihisa, Shimoda, Kazuya, Kikuchi, Ikuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JSLRT 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408177/ https://www.ncbi.nlm.nih.gov/pubmed/30089749 http://dx.doi.org/10.3960/jslrt.18011

Ejemplares similares

Clinical features and treatment outcomes of opportunistic infections among human T-lymphotrophic virus type 1 (HTLV-1) carriers and patients with adult T-cell leukemia-lymphoma (ATL) at a single institution from 2006 to 2016
por: Kawano, Noriaki, et al.
Publicado: (2019)

Characteristics of HAM/TSP after kidney transplantation from HTLV-1 positive living donors
por: Kimura, Miyuna, et al.
Publicado: (2015)

HAM/TSP in relatives of HAM/TSP cases and in relatives of asymptomatic HTLV-1 carriers
por: Alvarez, Carolina, et al.
Publicado: (2014)

Early diagnosis of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1 carrier clinic
por: Matsuzaki, Toshio, et al.
Publicado: (2014)

Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2017)

Association Between HTLV-1 Genotypes and Risk of HAM/TSP
por: Saito, Mineki
Publicado: (2019)

HTLV-1 proviral load of HAM/TSP patients according to new diagnostic criteria of HAM/TSP
por: Grassi, Maria F R, et al.
Publicado: (2011)

Comparison of HTLV-I Proviral Load in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I-Associated Myelopathy (HAM-TSP) and Healthy Carriers
por: Akbarin, Mohammad Mehdi, et al.
Publicado: (2013)

Molecular and clinical analyses of HTLV-1 subgroups associated with the risk of developing HAM/TSP.
por: Saito, Mineki, et al.
Publicado: (2015)

The plasticity of HTLV-1 infected CD4+CD25+CCR4+ T-cells through HTLV-1 tax in HAM/TSP
por: Araya, Natsumi, et al.
Publicado: (2011)

Vestibulospinal tract dysfunction in HTLV-1-asymptomatic infection and in HAM/TSP
por: Labanca, Ludimila, et al.
Publicado: (2014)

HTLV-1 proviral load as an indicative marker of HAM/TSP: a systematic review of studies of patients with HAM/TSP
por: Bassi, Shiva Shaan, et al.
Publicado: (2014)

Inflammation with HTLV-1-specific CTLs occurs in the spinal cord of HTLV-1 carriers and the brain of the patients with HAM/TSP
por: Matsuura, Eiji, et al.
Publicado: (2014)

An interferon signature is associated with HAM/TSP but not viral containment in HTLV-1 infection
por: Tattermusch, Sonja, et al.
Publicado: (2011)

HAM/TSP Pathogenesis: The Transmigration Activity of HTLV-1-Infected T Cells into Tissues
por: Nakamura, Tatsufumi
Publicado: (2023)

Biomarker to predict treatment response in patients with HTLV-1 associated myelopathy/Tropical spastic paraparesis (HAM/TSP)
por: Tamaki, Keiko, et al.
Publicado: (2015)

Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Baratella, Marco, et al.
Publicado: (2017)

Proteomic profiles among asymptomatic HTLV-1 carriers and HAM/TSP patients in Peru
por: Temoche, Morayma, et al.
Publicado: (2014)

Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2019)

Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan
por: Tsutsumi, Shuntaro, et al.
Publicado: (2019)

The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Rafatpanah, Houshang, et al.
Publicado: (2013)

HTLV-1 Integration into Transcriptionally Active Genomic Regions Is Associated with Proviral Expression and with HAM/TSP
por: Meekings, Kiran N., et al.
Publicado: (2008)

Neurological manifestations in HTLV-1 patients with overactive bladder syndrome. A precursor of HAM/TSP?
por: Costa, Davi, et al.
Publicado: (2011)

Integration site analysis in Japanese HTLV-1 infected asymptomatic carriers and HAM/TSP patients
por: Niederer, Heather, et al.
Publicado: (2014)

HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP
por: Niederer, Heather A, et al.
Publicado: (2014)

Nutritional status and behavioral factors of individuals with HTLV-1 and tropical spastic paraparesis (HAM / TSP)
por: Carvalho, Catia L, et al.
Publicado: (2015)

Cyclosporine for the Treatment of HTLV-1-Induced HAM/TSP: An Experience from a Case Report
por: Sánchez-Montalvá, Adrián, et al.
Publicado: (2015)

Comparison of Static Balance Control in Infected Htlv-1 Subjects with Different Tsp/Ham Diagnosis
por: Costa, Kelly Helorany Alves, et al.
Publicado: (2022)

Human T-lymphotropic Virus Type I (HTLV-I) Proviral Load and Clinical Features in Iranian HAM/TSP Patients: Comparison of HTLV-I Proviral Load in HAM/TSP Patients
por: Vakili, Rosita, et al.
Publicado: (2013)

Correlation of HTLV-1 proviral load and lymphocyte proliferation from asymptomatic HTLV-1-positive patients and HAM/TSP patients associated or not to skin disorders
por: Okajima, Renata, et al.
Publicado: (2014)

Refining the risk of HTLV-1-associated myelopathy in people living with HTLV-1: identification of a HAM-like phenotype in a proportion of asymptomatic carriers
por: Harding, Daniel, et al.
Publicado: (2022)

ATL Development after Adult Infection of HTLV‐1?
por: Hino, Shigeo
Publicado: (1989)

Epidemiology of HTLV-1 Infection and ATL in Japan: An Update
por: Iwanaga, Masako
Publicado: (2020)

CD64 as a biomarker and therapeutic target in HAM/TSP and HTLV-1-associated Infective Dermatitis
por: Khouri, Ricardo, et al.
Publicado: (2011)

Clinical manifestations in HTLV-1 infected individuals without HAM/TSP: Results of an 8 years cohort
por: Tanajura, Davi, et al.
Publicado: (2014)

Patterns of spinal cord atrophy in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP)
por: Charlip, Emily, et al.
Publicado: (2015)

Protein Profile of Blood Monocytes is Altered in HTLV-1 Infected Patients: Implications for HAM/TSP Disease
por: Echevarria-Lima, Juliana, et al.
Publicado: (2018)

Evaluation of interleukin-32 and cyclooxygenase-2 expression in HAM/TSP patients and HTLV-1 asymptomatic carriers
por: Hatatian, Niayesh, et al.
Publicado: (2021)

Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Burbelo, Peter D, et al.
Publicado: (2008)

High HTLV-I proviral load in patients with HAM/TSP and ATLL but not with other disorders
por: Altamirano, Natalia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_j61pnc47vn6tkkff2vm2hkpf5h